Cargando…
The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative Results
Background: Accumulating evidence indicates that mitochondrial energy failure is involved in the progressive axonal degeneration in multiple sclerosis (MS). In patients with MS, it has been shown that both levels of N-acetylaspartate (NAA), which is a marker of axonal mitochondrial energy, and cereb...
Autores principales: | Hostenbach, Stéphanie, Raeymaekers, Hubert, Van Schuerbeek, Peter, Vanbinst, Anne-Marie, Cools, Wilfried, De Keyser, Jacques, D'Haeseleer, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381129/ https://www.ncbi.nlm.nih.gov/pubmed/32765401 http://dx.doi.org/10.3389/fneur.2020.00674 |
Ejemplares similares
-
Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentan
por: Hostenbach, Stéphanie, et al.
Publicado: (2019) -
Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis
por: Hostenbach, Stéphanie, et al.
Publicado: (2020) -
Definition, prevalence and predictive factors of benign multiple sclerosis
por: Reynders, Tatjana, et al.
Publicado: (2017) -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis
por: Koudriavtseva, Tatiana, et al.
Publicado: (2020) -
Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis
por: Reynders, Tatjana, et al.
Publicado: (2019)